1. Home
  2. DLTH vs ANIX Comparison

DLTH vs ANIX Comparison

Compare DLTH & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

HOLD

Current Price

$2.41

Market Cap

121.1M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.97

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLTH
ANIX
Founded
1989
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.1M
104.0M
IPO Year
2015
1987

Fundamental Metrics

Financial Performance
Metric
DLTH
ANIX
Price
$2.41
$2.97
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$9.00
AVG Volume (30 Days)
74.3K
232.5K
Earning Date
03-12-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$590,561,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$2.33
52 Week High
$4.66
$5.46

Technical Indicators

Market Signals
Indicator
DLTH
ANIX
Relative Strength Index (RSI) 50.99 41.99
Support Level $2.30 $2.69
Resistance Level $2.47 $3.00
Average True Range (ATR) 0.12 0.19
MACD 0.02 0.01
Stochastic Oscillator 48.59 38.64

Price Performance

Historical Comparison
DLTH
ANIX

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: